In 2020, the World Health Organization (WHO) endorsed the molecular classification of endometrial carcinomas (EC) using surrogate markers and following a stepwise diagnostic algorithm 1,2. This ...
Ovarian cancer is the fifth leading cause of cancer death, and is the deadliest gynecologic malignancy among women in the United States [1]. Despite standard radical surgery and initial high response ...
5-FU/leucovorin (5FU/LV) combined with irinotecan (CPT-11) and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with metastatic pancreatic adenocarcinoma. Background: Previous analyses ...
Researchers from Lund University (Sweden) have investigated the tumor immune microenvironment of primary triple-negative breast cancer using digital image analysis of IHC-stained immune cells. To do ...
Boster Biological Technology, a life science reagent manufacturer based in Pleasanton, California, has broadened ...
The development of many different chromogens for light microscopy gives us the opportunity to explore different usage of multiplex immunohistochemistry (IHC) for clinical diagnostic purposes as well ...
What Is the Immunohistochemistry Test? The immunohistochemistry (IHC) test can tell your cancer doctor (oncologist) whether you have certain types of breast cancer. Professionals in a lab check a ...
A retrospective, cross-sectional study analyzed national trends of immunohistochemistry (IHC) use in the diagnosis of melanoma. Immunohistochemistry (IHC) has emerged as a clinical tool in skin ...
Functional Characterization and a Real-World Clinical Laboratory Pilot of the Foundation for the National Institutes of Health Circulating Tumor DNA Quality Control Materials A total of 871 patient ...
Histopathology is a cornerstone of clinical diagnosis, especially in cancer care. However, conventional chemical staining is ...
GLOSTRUP, Denmark, March 4, 2013 - Dako, an Agilent Technologies Company and worldwide provider of cancer diagnostics, unveiled the newest addition to its IHC portfolio at the 2013 USCAP congress in ...
This study optimizes immunohistochemical protocols for four key neurodegenerative markers—p‑Tau, β‑amyloid, α‑synuclein, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results